Sjogren's Syndrome Clinical Trials in Orlando, Florida
2 recruitingOrlando, Florida
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Sjogren's SyndromeSjogren DiseaseSjögren
Cullinan Therapeutics Inc.36 enrolled11 locationsNCT07041099
Recruiting
Rheumatology Diet Study
Rheumatoid ArthritisFibromyalgiaAnkylosing Spondylitis+8 more
University of Central Florida500 enrolled1 locationNCT06339957